| RLMD Shares Outstanding History Table | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
Below is a table of the RLMD shares outstanding history going back to 10/10/2019:
Also see: RLMD Market Cap History RLMD YTD Return |
RLMD Shares Outstanding History — Relmada Therapeutics Share Count Over Time
As of 5/7/2026 Relmada Therapeutics has 104.89 million RLMD shares outstanding. Investors often track the RLMD shares outstanding history to compare shareholder return trends against the change in share count over time.
This page shows RLMD share count trends over time, with 26 historical shares outstanding datapoints presented, dating back to 10/10/2019.
| RLMD Shares Outstanding History Chart | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
RLMD Historical Shares Outstanding: +43.08% CAGR 
Mouse over chart for data details
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||
| RLMD Stock Price Chart |
| About Relmada Therapeutics Inc |
| Relmada Therapeutics is a clinical-stage biotechnology company focused on the development of esmethadone (d-methadone, dextromethadone, REL-1017), an N-methyl-D-aspartate receptor antagonist. Esmethadone, an isomer of methadone, is a new chemical entity that addresses areas of medical need in the treatment of central nervous system diseases and other disorders. Co.'s primary product candidate, esmethadone, is being developed as an acting, oral agent for the treatment of depression and other potential indications. We show 26 historical shares outstanding datapoints in our coverage of RLMD's shares outstanding history. Understanding the changing numbers of RLMD shares outstanding — and comprehending the concept of differing number of shares outstanding in general comparing companies like RLMD versus peers — is critical for investors. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies. Furthermore, via issuance of new shares over time, or the repurchase of existing shares, the number of shares outstanding can fluctuate over the course of history. With this page we aim to empower investors researching RLMD by allowing them to research RLMD shares outstanding history as well as any other stock in our coverage universe. |
| RLMD Current Stock Quote |
Quotes delayed 20 minutes  Free RLMD Email Alerts:
Get Dividend Alerts 
Get SEC Filing Alerts
|
| Video: Shares Outstanding Importance | |
|
Video: Shares Outstanding Importance
| RLMD Share Performance |
| Shares Outstanding Peers |
| Relmada Therapeutics (RLMD) is categorized under the Healthcare sector; to help you further research historical shares outstanding numbers, below are some other companies in the same sector:
RLYB Shares Outstanding History RMD Shares Outstanding History RMED Shares Outstanding History RMTI Shares Outstanding History RNA Shares Outstanding History RNAC Shares Outstanding History RNAZ Shares Outstanding History RNTX Shares Outstanding History RNXT Shares Outstanding History RPHM Shares Outstanding History More Healthcare companies » |
RLMD Shares Outstanding History | www.SharesOutstandingHistory.com | Copyright © 2017 - 2026, All Rights Reserved
Nothing in SharesOutstandingHistory.com is intended to be investment advice, nor does it represent the opinion of, counsel
from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners.
None of the information contained herein constitutes a recommendation that any particular security, portfolio,
transaction, or investment strategy is suitable for any specific person. All viewers agree that under no
circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held
liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you
agree to the following Full Disclaimer & Terms of Use and
Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at
least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.
